A detailed history of Gryphon Financial Partners LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 586 shares of UTHR stock, worth $213,872. This represents 0.03% of its overall portfolio holdings.

Number of Shares
586
Holding current value
$213,872
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$311.04 - $363.55 $182,269 - $213,040
586 New
586 $209,000
Q3 2019

Nov 07, 2019

SELL
$74.85 - $85.99 $2,395 - $2,751
-32 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$76.06 - $120.81 $2,433 - $3,865
32 New
32 $2,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.